chitosan has been researched along with thioguanine anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasanzade, Z; Raissi, H | 1 |
| Devi, VR; Dhanalakshmi, H; Gomes, AR; Govindappa, PK; Kalmath, GP; Kumar, KRA; Kumar, PR; Kumar, SN; Metta, M; Narayanaswamy, HD; Prakash, N; Rajashekaraiah, R; Rao, GS; Rao, S; Rathnamma, D; Ruban, SW; Sahadev, A; Santhosh, CR; Satyanarayan, K; Sunilchandra, U; Swamy, MN | 1 |
2 other study(ies) available for chitosan and thioguanine anhydrous
| Article | Year |
|---|---|
Assessment of the chitosan-functionalized graphene oxide as a carrier for loading thioguanine, an antitumor drug and effect of urea on adsorption process: Combination of DFT computational and molecular dynamics simulation studies.
Topics: Adsorption; Algorithms; Antineoplastic Agents; Chitosan; Density Functional Theory; Graphite; Hydrogen Bonding; Models, Chemical; Molecular Conformation; Molecular Dynamics Simulation; Nanostructures; Structure-Activity Relationship; Thioguanine; Urea | 2019 |
Anticancer efficacy of 6-thioguanine loaded chitosan nanoparticles with or without curcumin.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Chitosan; Curcumin; Drug Carriers; Drug Liberation; Humans; MCF-7 Cells; Nanoparticles; Particle Size; Thioguanine | 2020 |